Pravastatin provides antioxidant activity and protection of erythrocytes loaded primaquine

International Journal of Medical Sciences

Volumn 7, Issue 6, 2010, Pages 358-365

  Alanazi, Fars K ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Drug delivery; Erythrocytes; Oxidative stress; Pravastatin; Primaquine

Indexed keywords

BIOLOGICAL MARKER; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; PRIMAQUINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE DISORDER; ERYTHROCYTE FRAGILITY; ERYTHROCYTE STRUCTURE; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; SCANNING ELECTRON MICROSCOPY;

EID: 78649647811     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.7.358     Document Type: Article

References (35)

1. Maurizio M, Luciano A, Walter M. The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenetic implications for vascular diseases. Cardiovas Res. 2007; 75: 21-28.
2. Çimen MYB. Free radical metabolism in human erythrocytes. Clinica Chimica Acta. 2008; 390: 1-11
3. Durak I, Kavutcu M, Çimen MYB, Elgün S, Öztürk H.S. Oxidant/antioxidant status of erythrocytes from patients with chronic renal failure: effects of hemodialysis. Med Princ Pract. 2001; 10:187-90.
4. Asgary S, Naderi GH, Askari N. Protective effect of flavonoids against red blood cell hemolysis by free radicals. Exp Clin Cardiol. 2005; 10(2):88-90.
5. Grinberg LN, Rachmilewitz EA, Newmark H. Protective effects of rutin against hemoglobin oxidation. Biochem Pharmacol. 1994; 48: 643-649.
6. Robaszkiewicz A, Bartosz G, Soszynski M. N-chloroamino acids cause oxidative protein modifications in the erythrocytes membrane. Mech Ageing Dev. 2008; 129: 572-529.
7. Prasanthi K, Muralidhara, Rajini PS. Morphological and biochemical perturbations in rat erythrocytes following in vitro exposure to Fenvalerate and its metabolite. Toxicol In Vitro. 2005;19: 449-456.
8. Fraser IM, Vessel ES. Effects of metabolites of primaquine and acetanilide on normal and glucose-6- phosphate dehydrogenase-deficient erythrocytes. J Pharm Exp Ther. 1968; 162: 155-165.
9. Thornally PJ, Stern A, Bannister JV. A mechanism for primaquine mediated oxidation of NADPH in red blood cells. Biochem Pharmacol. 1983; 32: 3571-3575.
10. Bowman ZS, Morrow JD, Jollow D J, McMillan D. C. Primaquine-Induced Hemolytic Anemia: Role of Membrane Lipid Peroxidation and Cytoskeletal Protein Alterations in the He motoxicity of 5-Hydroxyprimaquine. J Pharmacol Exp Ther. 2005; 314: 838-845.
11. Sulekha M, Satish Y, Sunita Y, Rajesh KN. Antioxidants: A Review. J Chem and Pharmaceu Res. 2009; 1:102-104
12. Wainwright CL. Statins: is there no end to their usefulness? Cardiovasc Res. 2005; 65:296-298.
13. Liao JK. Effect of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol. 2005; 96: 24F-33F.
14. Li X, Liu C, Cui J, Dong M, Peng CH, Li QS, Cheng JL, Jiang SL, Tian Y. Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease. Basic Clin Pharmacol Toxicol. 2009; 104: 101-106.
15. Kassan M, Montero MJ, Sevilla MA. Chronic treatment with pravastatin prevents cardiovascular alterations produced at early hypertensive stage. Br J Pharmacol. 2009;158: 541-547.
16. Beutler E. Red Cell Metabolism. New York: Grune and Stratton Inc. 1971.
17. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys. 1959; 82: 70-77.
18. Levine L, Williams J, Stadtman R, Shacter E. Carbonyl assay for determination of oxidatively modified proteins. Methods Enzymol. 1994; 233: 346-357.
19. Lowery OH, Rosenbrough NJ, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951; 193: 265-75.
20. Ohkawa H, Ohisshi N, Yagi K. Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-358.
21. Kraus A, Roth HP, Kirchgessner M. Supplementation with Vitamin C, Vitamin E or b-carotene influences osmotic fragility and oxidative damage of erythrocytes of zinc-deficient rats. J Nutr. 1997; 127: 1290-1296.
22. Lajos N, Miki N, Sandor S. Protein and non-protein sulfhydryls and disulfides in gastric mucosa and liver after gastrotoxic chemicals and sucralfate: Possible new targets of pharmacologic agents. World J Gastroenterol. 2007; 13: 2053-2060
23. Augusto O, Weingrill CLV, Schreier S, Amemiya H. Hydroxyl radical formation as a result of the interaction between primaquine and reduced pyridine nucleotides. Arch Biochim Biophys. 1986; 244: 147-155.
24. Sanguigni V, Pignatelli P, Caccese D. Atorvastatin decreases platelet superoxide anion production in hypercholesterolemic patients. Eur Heart J. 2002; 4:372.
25. Carty JL, Bevan R, Waller H, Mistry N, Cooke M, Lunec J, Griffiths HR. The effects of vitamin C supplementation on protein oxidation in healthy volunteers. Biochem Biophys Res Com. 2000; 273: 729-735.
26. Karabulut I, Balkanci ZD, Pehlivanoglu B, Erdem A, Fadillioglu E. Effect of tol uene on erythrocytes membrane stability under in vivo and in vitro conditions with assessment of oxidant/antioxidant status. Toxicol Ind Health. 2009; 25: 545-50.
27. Amici A, Levine RL, Tsai L, Stadtman ER. Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem. 1989; 264: 3341-3346
28. Beppu M, Inoue M, Ishikawa T, Kikugawa K. Presence of membrane-bound proteinases that preferentially degrade oxidatively damaged erythrocytes membrane proteins as secondary antioxidant defense. Biochim Biophys Acta. 1994; 1196:81-87.
29. Broncel M, Koter-Michalak M, Chojnowska-Jezierska J. The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Zegl Lek. 2006; 63:738-742.
30. Maria K, Ida F, Marlena B, and Julita C. Effects of simvastatin and pravastatin on peroxidation of erythrocytes plasma membrane lipids in patients with type 2 hypercholesterolemia. Can J Physiol Pharmacol. 2003; 81: 485-492
31. Krukoski DW, Comar SR, Claro LM, Leonart MS, Nascimento AJ. Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxides oxidative damage in human erythrocytes. Hematology. 2009; 14:168-172.
32. Okwusidi JI. Long term storage stabilizes human erythrocytes membrane in Nigerian black males. African J Biomed Res. 2004; 7: 9-12.
33. Gul O, Selda K, Yusuf O, Gulcin A, Mujdat U. Lipid and protein oxidation in erythrocytes membranes of hypercholesterolemic subjects. Clin Biochem. 2001; 34: 335-339.
34. Chikezie, PC, Uwakwe AA, Monago CC. Studies of human HbAA erythrocytes osmotic fragility index of non malarious blood in the presence of five antimalarial drugs. J Cell and Animal Biol. 2009; 3: 39-43.
35. Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocytes indexes. The Journal of pediatrics. 1997; 130: 957-960.